{"id":3953,"count":14,"description":"Nakupte l\u00e9ky na sn\u00ed\u017een\u00ed lipid\u016f online \u2014 atorvastatin, rosuvastatin, simvastatin, pitavastatin, ezetimib, fenofibr\u00e1t a cholestyramin \u2014 pro prim\u00e1rn\u00ed a sekund\u00e1rn\u00ed kardiovaskul\u00e1rn\u00ed prevenci.<\/strong> Vysok\u00fd cholesterol (zv\u00fd\u0161en\u00fd LDL-C a non-HDL-C) je hlavn\u00edm modifikovateln\u00fdm faktorem infarktu myokardu, ischemick\u00e9 c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhody a perifern\u00edho arteri\u00e1ln\u00edho onemocn\u011bn\u00ed. Sm\u011brnice ESC\/EAS z roku 2019, AHA\/ACC z roku 2018 a lipidov\u00e9 sm\u011brnice ACC\/AHA z roku 2025 stanovuj\u00ed sn\u00ed\u017een\u00ed LDL-C jako hlavn\u00ed intervenci \u2014 ka\u017ed\u00e9 sn\u00ed\u017een\u00ed LDL-C o 1 mmol\/l (~38 mg\/dl) sni\u017euje kardiovaskul\u00e1rn\u00ed p\u0159\u00edhody o 20\u201325 %<\/strong> v populac\u00edch s prim\u00e1rn\u00ed prevenc\u00ed, sekund\u00e1rn\u00ed prevenc\u00ed, diabetem, chronick\u00fdm onemocn\u011bn\u00edm ledvin a po c\u00e9vn\u00ed mozkov\u00e9 p\u0159\u00edhod\u011b. Volba l\u00e9ku z\u00e1vis\u00ed na v\u00fdchoz\u00ed hladin\u011b LDL-C, riziku ASCVD, toleranci statin\u016f, hladin\u011b triglycerid\u016f a t\u011bhotenstv\u00ed.Vysoce \u00fa\u010dinn\u00e9 statiny<\/strong> (sn\u00ed\u017een\u00ed LDL-C \u226550 %). Atorvatin<\/a> (atorvastatin 5 mg) a Thyronorm<\/a> (atorvastatin) pokr\u00fdvaj\u00ed lipofiln\u00ed molekulu metabolizovanou CYP3A4 \u2014 molekulu Lipitoru, kter\u00e1 je l\u00e9kem prvn\u00ed volby pro sekund\u00e1rn\u00ed prevenci v d\u00e1vk\u00e1ch 40\u201380 mg. Rosuvastatinov\u00e9 prot\u011bj\u0161ky Crestor<\/a>, Sim Hdl<\/a>, Rosu HDL<\/a>, a Rosuline<\/a> poskytuj\u00ed nejv\u011bt\u0161\u00ed sn\u00ed\u017een\u00ed LDL na miligram (rosuvastatin 20 mg \u2248 atorvastatin 40 mg) s hydrofiln\u00ed kinetikou a minim\u00e1ln\u00ed interakc\u00ed s CYP3A4 \u2014 preferovan\u00e9 u pacient\u016f u\u017e\u00edvaj\u00edc\u00edch inhibitory CYP3A4 (klarithromycin, diltiazem, antimykotika) nebo u t\u011bch, kte\u0159\u00ed m\u011bli svalov\u00e9 p\u0159\u00edznaky souvisej\u00edc\u00ed se statiny p\u0159i u\u017e\u00edv\u00e1n\u00ed atorvastatinu.Statiny st\u0159edn\u00ed intenzity<\/strong> (30\u201349% sn\u00ed\u017een\u00ed LDL-C) pro prim\u00e1rn\u00ed prevenci nebo pacienty s intoleranc\u00ed na statiny. Str\u00e1nky o simvastatinu Simvatic<\/a>, Simlo 5<\/a>, Sim HDL<\/a>, a Simvotin<\/a> pokr\u00fdvaj\u00ed p\u016fvodn\u00ed statin z 90. let (FDA varov\u00e1n\u00ed z roku 2011 p\u0159ed myopati\u00ed omezilo d\u00e1vku na 80 mg). Rosu-HDL<\/a> (pitavastatin) je nejnov\u011bj\u0161\u00ed molekula, metabolizovan\u00e1 glukuronidac\u00ed m\u00edsto CYP enzymy \u2014 l\u00e9k volby u pacient\u016f po transplantaci u\u017e\u00edvaj\u00edc\u00edch cyklosporin, kde je v\u011bt\u0161ina statin\u016f kontraindikov\u00e1na.Nestatinov\u00e9 dopl\u0148ky a alternativy.<\/strong> Lipikard<\/a> (ezetimib 10 mg) blokuje st\u0159evn\u00ed vst\u0159eb\u00e1v\u00e1n\u00ed cholesterolu inhibic\u00ed NPC1L1 \u2014 p\u0159id\u00e1v\u00e1 ~24% pokles LDL nav\u00edc k jak\u00e9mukoli statinu (kardiovaskul\u00e1rn\u00ed benefit prok\u00e1zan\u00fd v studii IMPROVE-IT). Pivasta<\/a> (fenofibr\u00e1t) je agonista PPAR-\u03b1: sni\u017euje triglyceridy o 30\u201350% a je prvn\u00ed volbou u t\u011b\u017ek\u00e9 hypertriglyceridemie (>500 mg\/dL riziko pankreatitidy) nebo sm\u00ed\u0161en\u00e9 dyslipidemie. Ezedoc<\/a> (cholestyramin) je sekvestrant \u017elu\u010dov\u00fdch kyselin vhodn\u00fd pro pacienty s intoleranc\u00ed na statiny, d\u011bdi\u010dnou hypercholesterol\u00e9mii u d\u011bt\u00ed, cholestatick\u00e9 sv\u011bd\u011bn\u00ed a pr\u016fjmy zp\u016fsoben\u00e9 \u017elu\u010dov\u00fdmi kyselinami \u2014 nevst\u0159eb\u00e1v\u00e1 se a je kompatibiln\u00ed s t\u011bhotenstv\u00edm.Jak vybrat.<\/strong> ASCVD \u22657,5% 10let\u00e9 riziko nebo prok\u00e1zan\u00e9 kardiovaskul\u00e1rn\u00ed onemocn\u011bn\u00ed \u2192 vysoce intenzivn\u00ed statin (atorvastatin 40\u201380 mg nebo rosuvastatin 20\u201340 mg). LDL-C st\u00e1le nad c\u00edlem p\u0159i maxim\u00e1ln\u011b tolerovan\u00e9 d\u00e1vce statinu \u2192 p\u0159idejte ezetimib. Triglyceridy >500 mg\/dL \u2192 nejprve fenofibr\u00e1t (prevence pankreatitidy), pot\u00e9 statin. T\u011bhotenstv\u00ed \u2192 cholestyramin (jedin\u00fd hypolipidemik kompatibiln\u00ed s t\u011bhotenstv\u00edm \u2014 statiny absolutn\u011b kontraindikov\u00e1ny). Transplantace s cyklosporinem nebo preexistuj\u00edc\u00ed elevace jatern\u00edch enzym\u016f \u2192 pitavastatin. V\u0161echny hypolipidemika na MedsBase jsou generick\u00e9 l\u00e9ky schv\u00e1len\u00e9 FDA<\/strong> vyroben\u00e9 WHO-GMP certifikovan\u00fdmi v\u00fdrobci<\/strong>. Celosv\u011btov\u00e1 doprava. V\u011brnostn\u00ed body se po\u010d\u00edtaj\u00ed u ka\u017ed\u00e9 objedn\u00e1vky.\n\n2026 buyer's guide:<\/strong> Prohl\u00e9dn\u011bte si n\u00e1\u0161 v\u00fdb\u011br Nejlep\u0161\u00ed l\u00e9ky na cholesterol 2026<\/a> pro se\u0159azen\u00e9 tipy, srovn\u00e1vac\u00ed tabulku, d\u00e1vkov\u00e1n\u00ed a zkratku k rozhodnut\u00ed.","link":"https:\/\/medsbase.com\/cs\/high-cholesterol-treatments\/","name":"L\u00e9\u010dba vysok\u00e9ho cholesterolu","slug":"high-cholesterol-treatments","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat\/3953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product?product_cat=3953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}